General Information of Drug Therapeutic Target (DTT) (ID: TTA6ZER)

DTT Name Immunoglobulin G1k (IgG1k)
Gene Name IgG1k
DTT Type
Clinical trial target
[1]
UniProt ID
NOUNIPROTAC
TTD ID
T49689

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
NKTT-120 DMI7ZK3 Sickle-cell disorder 3A51 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Advances in Sickle Cell Therapies in the Hydroxyurea Era. Mol Med. 2014; 20(Suppl 1): S37-S42.